Matoba K, Dohi E, Choi E, Kano S
Front Mol Biosci. 2023; 9:1080140.
PMID: 36685285
PMC: 9853189.
DOI: 10.3389/fmolb.2022.1080140.
Cornean C, Catana A, Maniu A
Medicina (Kaunas). 2022; 58(8).
PMID: 36013573
PMC: 9415364.
DOI: 10.3390/medicina58081106.
Teslenko I, Trudeau J, Luo S, Watson C, Chen G, Truica C
J Pharmacol Exp Ther. 2022; 382(3):327-334.
PMID: 35793834
PMC: 9426760.
DOI: 10.1124/jpet.122.001232.
Djidrovski I, Georgiou M, Tasinato E, Leonard M, van den Bor J, Lako M
Cell Biol Toxicol. 2022; 39(1):1-18.
PMID: 35641671
PMC: 10042770.
DOI: 10.1007/s10565-022-09726-0.
Teslenko I, Watson C, Xia Z, Chen G, Lazarus P
Drug Metab Dispos. 2021; 49(12):1047-1055.
PMID: 34593616
PMC: 11025106.
DOI: 10.1124/dmd.121.000635.
GTSP1 expression in non-smoker and non-drinker patients with squamous cell carcinoma of the head and neck.
Soares P, Cury P, Mendoza Lopez R, Cernea C, Fukuyama E, Figueiredo D
PLoS One. 2017; 12(8):e0182600.
PMID: 28817620
PMC: 5560606.
DOI: 10.1371/journal.pone.0182600.
Measurement of absolute copy number variation of Glutathione S-Transferase M1 gene by digital droplet PCR and association analysis in Tunisian Rheumatoid Arthritis population.
Achour Y, Ben Kilani M, Ben Hamad M, Marzouk S, Mahfoudh N, Bahloul Z
J Clin Lab Anal. 2017; 32(3).
PMID: 28703442
PMC: 6816960.
DOI: 10.1002/jcla.22300.
Glutathione S-transferases deletions may act as prognosis and therapeutic markers in breast cancer.
Zago Campos C, Guembarovski R, Oliveira C, Hirata B, Vitiello G, Dias F
Clin Exp Med. 2017; 18(1):27-35.
PMID: 28455582
DOI: 10.1007/s10238-017-0461-6.
Gene Polymorphisms of Glutathione S-Transferase T1/M1 in Egyptian Children and Adolescents with Type 1 Diabetes Mellitus.
Barseem N, Elsamalehy M
J Clin Res Pediatr Endocrinol. 2016; 9(2):138-143.
PMID: 27908841
PMC: 5463286.
DOI: 10.4274/jcrpe.3690.
The synergy of tobacco and alcohol and glutathione S-transferase θ 1 gene deletion and oral squamous cell carcinoma.
D Mello S, Bavle R, Paremala K, Makarla S, Sudhakara M, Bhatt M
J Oral Maxillofac Pathol. 2016; 20(3):348-353.
PMID: 27721596
PMC: 5051279.
DOI: 10.4103/0973-029X.190898.
Systematic Review and Meta-Analysis of the Relationship between EPHX1 Polymorphisms and the Risk of Head and Neck Cancer.
Chen H, Ge L, Sui Q, Lin M
PLoS One. 2015; 10(4):e0123347.
PMID: 25923690
PMC: 4414537.
DOI: 10.1371/journal.pone.0123347.
Do genetic polymorphisms modulate response rate and toxicity of Cisplatin associated with radiotherapy in laryngeal squamous cell carcinoma?: a case report.
Lopes-Aguiar L, Visacri M, Nourani C, Dias Costa E, Nogueira G, Lima T
Medicine (Baltimore). 2015; 94(16):e578.
PMID: 25906090
PMC: 4602693.
DOI: 10.1097/MD.0000000000000578.
Evaluation of Glutathione S-transferase T1 (GSTT1) deletion polymorphism on type 2 diabetes mellitus risk in a sample of Yazdian females in Yazd, Iran.
Khalilzadeh S, Afrand M, Froozan-Nia S, Sheikhha M
Electron Physician. 2015; 6(3):856-62.
PMID: 25763158
PMC: 4324294.
DOI: 10.14661/2014.856-862.
Glutathione S-transferase M1 (GSTM1) and T1 (GSTT1) null polymorphisms and the risk of hypertension: a meta-analysis.
Ge B, Song Y, Zhang Y, Liu X, Wen Y, Guo X
PLoS One. 2015; 10(3):e0118897.
PMID: 25742618
PMC: 4351109.
DOI: 10.1371/journal.pone.0118897.
Glutathione s-transferase m1 and t1 gene polymorphisms are not associated with increased risk of gestational diabetes mellitus development.
Orhan O, Atalay M, Orhan F, Karkucak M, Centinkaya Demir B, Yakut T
West Indian Med J. 2014; 63(4):300-6.
PMID: 25429472
PMC: 4663914.
DOI: 10.7727/wimj.2013.128.
Genetic variations and head and neck cancer risks.
Masood N, Yasmin A, Kayani M
Mol Biol Rep. 2014; 41(4):2667-70.
PMID: 24452716
DOI: 10.1007/s11033-014-3125-6.
Investigating GSTT1 and GSTM1 null genotype as the risk factor of diabetes type 2 retinopathy.
Dadbinpour A, Sheikhha M, Darbouy M, Afkhami-Ardekani M
J Diabetes Metab Disord. 2013; 12(1):48.
PMID: 24355557
PMC: 7968338.
DOI: 10.1186/2251-6581-12-48.
DNA repair gene XRCC1 polymorphisms and head and neck cancer risk: an updated meta-analysis including 16344 subjects.
Lou Y, Peng W, Cao D, Xie J, Li H, Jiang Z
PLoS One. 2013; 8(9):e74059.
PMID: 24086310
PMC: 3781168.
DOI: 10.1371/journal.pone.0074059.
Modifying roles of glutathione S-transferase polymorphisms on the association between cumulative lead exposure and cognitive function.
Eum K, Wang F, Schwartz J, Hersh C, Kelsey K, Wright R
Neurotoxicology. 2013; 39:65-71.
PMID: 23958642
PMC: 3844089.
DOI: 10.1016/j.neuro.2013.08.002.
GSTM1 copy number and promoter haplotype as predictors for risk of recurrence and/or second primary tumor in patients with head and neck cancer.
Zhang X, Huang M, Wu X, Kadlubar S, Lin J, Yu X
Pharmgenomics Pers Med. 2013; 6:9-17.
PMID: 23526580
PMC: 3596140.
DOI: 10.2147/PGPM.S35949.